Japan BCG Laboratory was established in 1952 and has produced high-quality BCG (Bacillus-Calmette Guérin) vaccine ever since. Japan BCG Laboratory is the sole supplier of this vaccine in Japan.
Working with UNICEF, WHO and the Pan American Health Organization (PAHO), Japan BCG Laboratory has distributed its BCG vaccine in more than 50 countries worldwide, and has become a respected and longstanding supplier of high-quality products.
Japan BCG Laboratory has supplied more than 2 billion doses of BCG vaccine over the past 40 years.

In 1924, Dr Kiyoshi Shiga brought to Japan a BCG strain from the Pasteur Institute in Paris, France. The strain was sub-cultured and was subsequently named BCG Tokyo 172 strain. Under the auspices of the Japan Anti-Tuberculosis Association (JATA), the Research Institute of Tuberculosis (RIT) developed and produced dried BCG vaccine and tuberculin. In 1952, the production department of RIT became Japan BCG Laboratory. Since then, Japan BCG Laboratory has gained international recognition:

• ●In 1962, it began exporting intradermal BCG vaccine in collaboration with UNICEF.
• ●In 1965, the WHO recognized the freeze-dried BCG vaccine from BCG Tokyo 172 strain as an international reference preparation of BCG vaccine.

Japan BCG Laboratory puts customer needs first and foremost, prioritizing all associated activities to ensure the timely supply of BCG vaccines. This dedication to outstanding performance has earned Japan BCG Laboratory an exceptional reputation among its numerous clients. Throughout the whole activities, Japan BCG Laboratory continually strives for the prevention of tuberculosis all around the world.